That deserves a closer look: The recently announced partnership between Axxam S.p.A., a leading provider of integrated early discovery services, and Molecular Health GmbH, a pioneer in AI-powered data solutions for pharmaceutical R&D, is more than a standard collaboration. It exemplifies the convergence of consolidated in-vitro biology-led drug discovery with modern, data-intelligent drug development methodologies. As an example for breaking the silos of clinical and preclinical target validation.

Spain’s biotech sector drives innovation, economic growth, and scientific ­excellence. With strong R&D investment, global research impact, and a leading role in gender equality, it’s a key player in health, sustainability, and strategic autonomy. BIOSPAIN 2025 in Barcelona will showcase its potential and connect global biotech leaders.

Pichia pastoris (syn. Komagataella phaffii), a methylotrophic yeast, is a proven platform for pharmaceutical protein production. However, its potential reaches far beyond. As a reliable, scalable, and cost-efficient platform for recombinant protein expression, Pichia is equally suited for industrial enzymes, food & feed, diagnostics, and biomaterials.

In today’s rapidly evolving world, adapting to demand volatilities while ­ensuring uninterrupted supply of biological medicines is more critical than ever. At ­Boehringer Ingelheim, our global biopharmaceutical network delivers flexibility, resilience, and ­reliability. By leveraging harmonised procedures, standardised setups, and innovative logistics, we ­ensure the biologics we produce reach those in need – even during unexpected challenges.

In the life sciences industry, Quality Management (QM) has long been ­synonymous with compliance: checking boxes to meet regulatory demands. But that ­definition no longer holds up. Today, QM must do much more than ensure compliance; it needs to ­enable speed, scalability, and sustained innovation across complex, global operations. To do that, prominent gaps need to be filled.

It all began with a view from the window of the 15th floor of Bayer’s site in ­Berlin, reminiscent of Boston before it became one of the most important biotech hotspots in the world. This inspired the vision of developing the Bayer Campus into “Boston an der Spree” – a vibrant healthcare campus that fosters collaboration and innovation.

In life sciences, breakthroughs are reshaping healthcare faster than ever. But true leadership means going beyond the lab – understanding the complex ecosystem where ­science, policy, and business collide. For those struggling to navigate this complexity, WU ­Vienna’s Executive MBA offers the insights and connections needed to stay ahead in an ­unpredictable industry.

The Hamburg-based company Indivumed has repositioned itself, sending a clear message with a recent change in leadership: A new chapter is beginning with the focus on discovering and developing novel therapeutic targets for innovative cancer therapies. |transkript spoke with Prof. Dr. Hartmut Juhl and Dr. Matthias Evers.

CCU_Audience

UP Catalyst, Far Eastern New Century Corporation, and Oxylus Energy were recognised at the “Best CO2 Utilisation 2025” Innovation Award for transforming carbon emissions into high-performance battery materials, sustainable plastics for footwear and textiles, and methanol fuel, marking major strides toward a renewable carbon future.

Vetter_sustainability-report

The pharmaceutical service provider publishes its 2024 Sustainability Report.